Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

DOTAGA-FAP-2286-ALB

DOTAGA-FAP-2286-ALB is a derivative of Rofapitide tetraxetan. DOTAGA-FAP-2286-ALB is a selective fibroblast activation protein (FAP) inhibitor with an IC50 value of 67.5 nM. DOTAGA-FAP-2286-ALB enhances tumor retention via albumin interaction, prolonging blood circulation and improving radiometal complex stability (e.g., with 111In and 225Ac). DOTAGA-FAP-2286-ALB is promising for research of radionuclide therapy (TRT) of FAP-positive solid tumors[1].

Product Specifications

UNSPSC

12352005

Target

Drug Derivative; FAP

Related Pathways

Immunology/Inflammation; Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

99.29

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

O=C(CC[C@@H](C(N[C@H](C(O)=O)CCCCNC(CCCC1=CC=C(I)C=C1)=O)=O)NC(CCC(C(O)=O)N2CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC2)=O)NCCSCC3=CC(CSC[C@@H](C(N4[C@H](C(N5[C@H](C(N[C@@H]([C@H](O)C)C(N[C@H](C(N[C@H]6CC7=CC=CC=C7)=O)CCC(N)=O)=O)=O)CCC5)=O)CCC4)=O)NC(CCCCC)=O)=CC(CSC[C@@H](C(O)=O)NC6=O)=C3

Molecular Formula

C91H131IN16O25S3

Molecular Weight

2072.21

References & Citations

[1]Saito K, et al. Preclinical Characterization of Novel FAP-2286-Based Radioligand with Albumin Binder for Improved Tumor Retention. ACS Med Chem Lett. 2025 Mar 24;16 (4) :596-601.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, stored under nitrogen)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD45RO (190-2F2.5), CF568 conjugate, 0.1mg/mL
BNC681081-500 1x 500 µL

CD45RO (190-2F2.5), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD95 (B-R18), CF740 conjugate, 0.1mg/mL
BNC740305-100 1x 100 µL

CD95 (B-R18), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
AMACR / p504S (Prostate Cancer Marker) (AMACR/2748R), CF647 conjugate, 0.1mg/mL
BNC472748-500 1x 500 µL

AMACR / p504S (Prostate Cancer Marker) (AMACR/2748R), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Bcl-2 (8C8), CF647 conjugate, 0.1mg/mL
BNC470005-100 1x 100 µL

Bcl-2 (8C8), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
WT1 (Wilm's Tumor 1) (WT1/857), CF647 conjugate, 0.1mg/mL
BNC470857-100 1x 100 µL

WT1 (Wilm's Tumor 1) (WT1/857), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
P27 / KIP1 (DCS-72.F6 + KIP1/769 (SX53G8) ), CF640R conjugate, 0.1mg/mL
BNC401237-500 1x 500 µL

P27 / KIP1 (DCS-72.F6 + KIP1/769 (SX53G8) ), CF640R conjugate, 0.1mg/mL

Sign In for Pricing
View Details